Norwegian Pharmaceuticals & Biotech Most Popular Stocks

Circio Holding

Market Cap: NOK 1.8b

A biotechnology company, develops novel circular RNA expression technology for gene and cell therapy.

Thor Medical

Market Cap: NOK 1.6b

Produces and supplies alpha-particle emitters for cancer therapy in Norway.

Photocure

Market Cap: NOK 1.5b

Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.

ArcticZymes Technologies

Market Cap: NOK 955.0m

A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.

Nykode Therapeutics

Market Cap: NOK 909.4m

A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.

Vistin Pharma

Market Cap: NOK 900.2m

Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) in Africa, Europe, Asia, and North and South America.

Hofseth BioCare

Market Cap: NOK 759.9m

Produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States.

Lytix Biopharma

Market Cap: NOK 729.0m

A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.

Zelluna

Market Cap: NOK 670.6m

A clinical-stage biotechnology company, engages in the development of T-cell receptor guided natural killer cell therapies in Norway.

Norda

Market Cap: NOK 443.4m

A biotechnology company, engages in the cancer diagnostic activities.

Navamedic

Market Cap: NOK 384.9m

A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.

Oncoinvent

Market Cap: NOK 362.8m

A clinical stage company, develops radiopharmaceutical therapies against cancer.

SoftOx Solutions

Market Cap: NOK 247.2m

Operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway.

Arctic Bioscience

Market Cap: NOK 80.9m

A clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific.

EXACT Therapeutics

Market Cap: NOK 45.9m

A clinical stage biopharmaceutical company, develops a novel ultrasound-mediated technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT) in Norway.